3
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Terminated
2
Recruiting
2
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
4
Gynecologic
2
Genitourinary
2
Dermatologic
2
Thoracic
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Gastrointestinal
1
Breast
1
Conditions
Prostatic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Docetaxel
33
Radiosurgery
22
Radiotherapy
21
Sunitinib
20
pembrolizumab
17
Gemcitabine
16
Cisplatin
16
Androgen Antagonists
15
enzalutamide
13
Nivolumab
13
Goserelin
12
Blood Specimen Collection
12
aldesleukin
11
Surveys and Questionnaires
11
Prednisone
11
Leuprolide
11
Cyclophosphamide
11
Abiraterone Acetate
11
Bevacizumab
10
bicalutamide
9
Multiparametric Magnetic Resonance Imaging
9
Carboplatin
9
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
8
Gonadotropin-Releasing Hormone
8
Filgrastim
8
Epirubicin
8
Chemotherapy, Adjuvant
8
Brachytherapy
8
toripalimab
7
tislelizumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Data Collection
×
Genitourinary
×
Clear all
NCT05456074
2022-11-25
IMCOR
Institut de cancérologie Strasbourg Europe
Unknown
600 enrolled
NCT05612841
2022-11-10
IN-PROVE
Centre Hospitalier Universitaire de Besancon
Unknown
264 enrolled